Dr. Beat Widler
Dr. Widler is a PhD graduate from the Swiss Federal Institute of Technology (ETHZ) in Zurich, and holds the Swiss Diploma of Pharmaceutical Medicine. He operates as an independent CQA, Quality Risk Management, GCP & Pharmacovigilance Auditing Expert and is Managing Partner at Widler & Schiemann AG in Zug Switzerland.
Over his 35 year career in the pharma industry, he built his extensive knowledge in the field of clinical development. From 1986 till 2012 Dr. Widler worked for Hoffmann-La Roche first as an International Drug Regulatory Affairs officer, then as a Senior Clinical Research Scientist. In 1993 he joined the International Clinical Quality Assurance department. From 1997 to 2011 he was the Global Head of the Department for Quality, Ethics and Systems’ in Roche Pharma. In 2012 he co-founded with Dr. Peter Schiemann Widler & Schiemann Ltd., a Management Consulting firm specializing in supporting their clients in quality management and drug development of new medications.
Dr. Widler is an active member in a variety of international GCP work groups and he regularly lectures at DIA, EFGCP, WHO, ECPM (University Basel) seminars. In the areas of quality risk management and Quality by Design he is an active member of the CTTI (Clinical Trials Transformation Initiative) and OECD working groups. He is a founding member of ACRES – the Alliance for Clinical Research Excellence and Safety (www.acresglobal.net), a founding member of the Midata Cooperative (http://www.datenundgesundheit.ch) and a faculty member of Basel University.